# Therapeutic Equivalence Trial of Two Hormonal-IUDs in Patients With Heavy Menstrual Bleeding

> **NCT01695902** · PHASE3 · COMPLETED · sponsor: **Uteron Pharma S.A.** · enrollment: 280 (actual)

## Conditions studied

- Heavy Menstrual Bleeding

## Interventions

- **DRUG:** Levosert-20
- **DRUG:** Mirena

## Key facts

- **NCT ID:** NCT01695902
- **Lead sponsor:** Uteron Pharma S.A.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-12
- **Primary completion:** 2010-01
- **Final completion:** 2011-09
- **Target enrollment:** 280 (ACTUAL)
- **Last updated:** 2012-09-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01695902

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01695902, "Therapeutic Equivalence Trial of Two Hormonal-IUDs in Patients With Heavy Menstrual Bleeding". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01695902. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*